199 related articles for article (PubMed ID: 12604714)
1. Pharmacodynamics of selective androgen receptor modulators.
Yin D; Gao W; Kearbey JD; Xu H; Chung K; He Y; Marhefka CA; Veverka KA; Miller DD; Dalton JT
J Pharmacol Exp Ther; 2003 Mar; 304(3):1334-40. PubMed ID: 12604714
[TBL] [Abstract][Full Text] [Related]
2. A selective androgen receptor modulator for hormonal male contraception.
Chen J; Hwang DJ; Bohl CE; Miller DD; Dalton JT
J Pharmacol Exp Ther; 2005 Feb; 312(2):546-53. PubMed ID: 15347734
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation.
Jones A; Hwang DJ; Duke CB; He Y; Siddam A; Miller DD; Dalton JT
J Pharmacol Exp Ther; 2010 Aug; 334(2):439-48. PubMed ID: 20444881
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I.
Aikawa K; Miyawaki T; Hitaka T; Imai YN; Hara T; Miyazaki J; Yamaoka M; Kusaka M; Kanzaki N; Tasaka A; Shiraishi M; Yamamoto S
Bioorg Med Chem; 2015 May; 23(10):2568-78. PubMed ID: 25862209
[TBL] [Abstract][Full Text] [Related]
6. Anti-androgenic effects of S-40542, a novel non-steroidal selective androgen receptor modulator (SARM) for the treatment of benign prostatic hyperplasia.
Nejishima H; Yamamoto N; Suzuki M; Furuya K; Nagata N; Yamada S
Prostate; 2012 Oct; 72(14):1580-7. PubMed ID: 22430536
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of AC-262536, a novel selective androgen receptor modulator.
Piu F; Gardell LR; Son T; Schlienger N; Lund BW; Schiffer HH; Vanover KE; Davis RE; Olsson R; Bradley SR
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):129-37. PubMed ID: 18164613
[TBL] [Abstract][Full Text] [Related]
8. 1-(2-Hydroxy-2-methyl-3-phenoxypropanoyl)indoline-4-carbonitrile derivatives as potent and tissue selective androgen receptor modulators.
Piatnitski Chekler EL; Unwalla R; Khan TA; Tangirala RS; Johnson M; St Andre M; Anderson JT; Kenney T; Chiparri S; McNally C; Kilbourne E; Thompson C; Nagpal S; Weber G; Schelling S; Owens J; Morris CA; Powell D; Verhoest PR; Gilbert AM
J Med Chem; 2014 Mar; 57(6):2462-71. PubMed ID: 24527807
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a 5-day Hershberger assay using young mature male rats: methyltestosterone and p,p'-DDE, but not fenitrothion, exhibited androgenic or antiandrogenic activity in vivo.
Sunami O; Kunimatsu T; Yamada T; Yabushita S; Sukata T; Miyata K; Kamita Y; Okuno Y; Seki T; Nakatsuka I; Matsuo M
J Toxicol Sci; 2000 Dec; 25(5):403-15. PubMed ID: 11201171
[TBL] [Abstract][Full Text] [Related]
10. Selective androgen receptor modulator treatment improves muscle strength and body composition and prevents bone loss in orchidectomized rats.
Gao W; Reiser PJ; Coss CC; Phelps MA; Kearbey JD; Miller DD; Dalton JT
Endocrinology; 2005 Nov; 146(11):4887-97. PubMed ID: 16099859
[TBL] [Abstract][Full Text] [Related]
11. The para substituent of S-3-(phenoxy)-2-hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamides is a major structural determinant of in vivo disposition and activity of selective androgen receptor modulators.
Kim J; Wu D; Hwang DJ; Miller DD; Dalton JT
J Pharmacol Exp Ther; 2005 Oct; 315(1):230-9. PubMed ID: 15987833
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and in vivo SAR of a novel series of pyrazolines as potent selective androgen receptor modulators.
Zhang X; Li X; Allan GF; Sbriscia T; Linton O; Lundeen SG; Sui Z
J Med Chem; 2007 Aug; 50(16):3857-69. PubMed ID: 17636947
[TBL] [Abstract][Full Text] [Related]
13. 17beta-hydroxy-5alpha-androst-1-en-3-one (1-testosterone) is a potent androgen with anabolic properties.
Friedel A; Geyer H; Kamber M; Laudenbach-Leschowsky U; Schänzer W; Thevis M; Vollmer G; Zierau O; Diel P
Toxicol Lett; 2006 Aug; 165(2):149-55. PubMed ID: 16621347
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo structure-activity relationships of novel androgen receptor ligands with multiple substituents in the B-ring.
Chen J; Hwang DJ; Chung K; Bohl CE; Fisher SJ; Miller DD; Dalton JT
Endocrinology; 2005 Dec; 146(12):5444-54. PubMed ID: 16166218
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of an imidazolopyrazole as novel selective androgen receptor modulator.
Zhang X; Allan GF; Tannenbaum P; Sbriscia T; Linton O; Lai MT; Haynes-Johnson D; Bhattacharjee S; Lundeen SG; Sui Z
J Steroid Biochem Mol Biol; 2013 Mar; 134():51-8. PubMed ID: 23098693
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators.
Marhefka CA; Gao W; Chung K; Kim J; He Y; Yin D; Bohl C; Dalton JT; Miller DD
J Med Chem; 2004 Feb; 47(4):993-8. PubMed ID: 14761201
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats.
Ostrowski J; Kuhns JE; Lupisella JA; Manfredi MC; Beehler BC; Krystek SR; Bi Y; Sun C; Seethala R; Golla R; Sleph PG; Fura A; An Y; Kish KF; Sack JS; Mookhtiar KA; Grover GJ; Hamann LG
Endocrinology; 2007 Jan; 148(1):4-12. PubMed ID: 17008401
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of sexual behavior and motor activity deficits in a castrated rodent model with a selective androgen receptor modulator SARM-2f.
Morimoto M; Amano Y; Oka M; Harada A; Fujita H; Hikichi Y; Tozawa R; Yamaoka M; Hara T
PLoS One; 2017; 12(12):e0189480. PubMed ID: 29216311
[TBL] [Abstract][Full Text] [Related]
19. Considerations, possible contraindications, and potential mechanisms for deleterious effect in recreational and athletic use of selective androgen receptor modulators (SARMs) in lieu of anabolic androgenic steroids: A narrative review.
Machek SB; Cardaci TD; Wilburn DT; Willoughby DS
Steroids; 2020 Dec; 164():108753. PubMed ID: 33148520
[TBL] [Abstract][Full Text] [Related]
20. Pharmacology, pharmacokinetics, and metabolism of acetothiolutamide, a novel nonsteroidal agonist for the androgen receptor.
Yin D; Xu H; He Y; Kirkovsky LI; Miller DD; Dalton JT
J Pharmacol Exp Ther; 2003 Mar; 304(3):1323-33. PubMed ID: 12604713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
